1. Home
  2. ICCC vs TACT Comparison

ICCC vs TACT Comparison

Compare ICCC & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$5.92

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

HOLD

Current Price

$4.03

Market Cap

41.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
TACT
Founded
1982
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
55.5M
41.6M
IPO Year
1987
1996

Fundamental Metrics

Financial Performance
Metric
ICCC
TACT
Price
$5.92
$4.03
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
16.0K
50.7K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$27,769,304.00
$50,258,000.00
Revenue This Year
N/A
$21.67
Revenue Next Year
N/A
$7.63
P/E Ratio
$22.47
N/A
Revenue Growth
16.49
8.27
52 Week Low
$4.28
$3.12
52 Week High
$7.60
$5.70

Technical Indicators

Market Signals
Indicator
ICCC
TACT
Relative Strength Index (RSI) 52.09 35.19
Support Level $4.72 $4.01
Resistance Level $6.19 $4.18
Average True Range (ATR) 0.27 0.16
MACD 0.03 -0.02
Stochastic Oscillator 58.25 12.86

Price Performance

Historical Comparison
ICCC
TACT

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: